Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones
about
DNA gyrase, topoisomerase IV, and the 4-quinolonesLevofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureusCharacterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.Molecular detection of antimicrobial resistanceSequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetiiHigh-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA.Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureusMolecular diagnostics of clinically important staphylococci.Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faeciumActivities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains.Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.Topoisomerase mutations in trovafloxacin-resistant Staphylococcus aureusHydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus.Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics.Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance.
P2860
Q24643546-F8BDA08B-6789-4909-8581-7D9CEBBCF200Q28379074-7A79F4F9-DC60-41AC-8C4B-CE4EC56EC191Q33695982-1D26BD4F-E6FA-433E-98D1-A33CAAF3EEE6Q33975793-17B6AA58-ADDD-43E1-A332-B818CE854FBAQ35123601-CE2C030A-5BC6-4C93-A72C-4FC662053C21Q35129977-BF04CFB9-E754-4BD1-AE25-2CF944AD36DCQ35139457-A8EF102B-CC86-421A-908A-7FEDFCA863B0Q35941369-D29FDCBC-B9C4-4F32-A7E9-A64242A82AA5Q39469894-29E25745-9A63-440E-9CAF-E9BEC45D6EFCQ39470617-58BBAD0B-94BD-4297-BBD4-761AC6A57E59Q39471404-18EE041E-2511-47C9-8980-5374DF648BF6Q39556591-22B7B185-A6C0-4FDB-80FD-B2F54667691FQ39558211-54F2C212-5F8F-4864-80C0-933A2A803638Q39559020-E51AAF48-6D90-4E33-83BB-3501C837BC80Q39782564-A2C5B09C-E116-4999-80AD-A6A1964B0A9FQ39785507-94843458-4327-4F84-A660-19AA15E28D18Q42408718-C9F90759-6B01-4195-8B45-24F6B6F057E4
P2860
Incidence of various gyrA mutants in 451 Staphylococcus aureus strains isolated in Japan and their susceptibilities to 10 fluoroquinolones
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@ast
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@en
type
label
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@ast
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@en
prefLabel
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@ast
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@en
P2093
P2860
P356
P1476
Incidence of various gyrA muta ...... ilities to 10 fluoroquinolones
@en
P2093
P2860
P304
P356
10.1128/AAC.39.7.1414
P407
P577
1995-07-01T00:00:00Z